omega-n-methylarginine has been researched along with Hypotension in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 24 (75.00) | 18.2507 |
2000's | 6 (18.75) | 29.6817 |
2010's | 2 (6.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hobbs, AJ; Sand, CA | 1 |
Barbara, JA; Hewitson, CL; Mangoni, AA; McAteer-Carr, B; Whiting, MJ; Woodman, RJ | 1 |
Kondapaneni, M; Laubach, VE; McGregor, JR; Salvemini, D; Samlowski, WE; Tharkar, S | 1 |
Chelly, B; Chelly, JE; Doursout, MF; Fischer, UM; Hartley, CJ; Liang, Y; Oguchi, T | 1 |
Kondapaneni, M; Laubach, VE; McGregor, JR; Salvemini, D; Samlowski, WE | 1 |
Boeynaems, JM; Buurman, W; Preiser, JC; Vincent, JL; Wachel, D; Zhang, H | 1 |
Blantz, RC | 1 |
Agarwal, N; Chalasani, S; Lentz, KE; Lomis, TJ; Lowenstein, CJ; McMillan, A; Rhoads, JE; Siffring, CW; Stauffer, KE; Ziegler, DW | 1 |
Chang, CH; Chang, JP; Lin, PJ | 1 |
Gidday, JM; Zhu, Y | 1 |
Bättig, U; Cakmakci, M; Geroulanos, S; Schilling, J | 1 |
Ewer, M; Fonseca, GA; Griffith, OW; Jones, E; Kilbourn, RG; Logothetis, CJ; Price, K; Striegel, A | 1 |
Alak, AM; Cromeens, DM; Flaherty, MJ; Griffith, OW; Gross, SS; Kilbourn, RG; Owen-Schaub, LB; Santee, SM | 1 |
Klabunde, RE; Ritger, RC; Slayton, KJ | 1 |
Fukuuchi, Y; Gomi, S; Mihara, B; Nagata, E; Nogawa, S; Nozaki, H; Shirai, T; Tanaka, K | 1 |
Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 1 |
Hisamochi, K; Raikar, BL; Raikar, GV; Schaff, HV | 1 |
Griffith, OW; Kilbourn, RG | 1 |
Chaudhry, GM; Esakof, DD; Hariawala, M; Horowitz, JR; Isner, JM; Rivard, A; Sheriff, DD; Symes, JF; van der Zee, R | 1 |
Baylis, SA; Charles, IG; Heaton, ND; Martin, JF; McPeake, JR; Moncada, S; Robinson, NM; Smith, RE; Williams, R | 1 |
Banks, SM; Cobb, JP; Cunnion, RE; Danner, RL; Eichacker, PQ; Freeman, BD; Karzai, W; Natanson, C; Quezado, MJ; Quezado, ZM; Sevransky, JE; Yan, L | 1 |
Ballejo, G; Resende, AC; Salgado, MC | 1 |
Ekin, S; Evora, PR; Pearson, PJ; Schaff, HV | 1 |
Fonseca, GA; Griffith, OW; Kilbourn, RG; Trissel, LA | 1 |
Halliwill, JR; Joyner, MJ; Minson, CT | 1 |
Hirooka, Y; Kishi, T; Sakai, K; Shigematsu, H; Shimokawa, H; Takeshita, A | 1 |
Elmore, SP; Oliver, JD; Simpson, LM; Watts, JA | 1 |
Helgren, MC; Klabunde, RE | 1 |
Newman, CM; O'Shaughnessy, KM; Warren, JB | 1 |
Calignano, A; Mancuso, F; Persico, P; Sorrentino, L | 1 |
Ayrancioglu, K; Evora, PR; Pearson, PJ; Schaff, HV | 1 |
Adams, J; Griffith, OW; Gross, SS; Jubran, A; Kilbourn, RG; Levi, R; Lodato, RF | 1 |
4 review(s) available for omega-n-methylarginine and Hypotension
Article | Year |
---|---|
The nuances of NO synthase regulation in sepsis: Could targeting BH4 be the answer?
Topics: Animals; Biopterins; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hypotension; Nitric Oxide Synthase; omega-N-Methylarginine; Sepsis | 2016 |
Vascular biology: relevance of nitric oxide in vascular and nonvascular tissue with normal and decreased renal function.
Topics: Amino Acid Oxidoreductases; Arginine; Endothelium, Vascular; Enzyme Induction; Hemodynamics; Humans; Hypotension; Inflammation; Kidney Diseases; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Shock, Septic | 1994 |
Design of nitric oxide synthase inhibitors and their use to reverse hypotension associated with cancer immunotherapy.
Topics: Animals; Arginine; Blood Pressure; Dogs; Drug Design; Enzyme Inhibitors; Humans; Hypotension; Immunotherapy; Interleukin-2; Neoplasms; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 1997 |
Role of non-nitric oxide non-prostaglandin endothelium-derived relaxing factor(s) in bradykinin vasodilation.
Topics: Animals; Bradykinin; Cannabinoid Receptor Modulators; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Hypotension; Nitric Acid; Nitric Oxide; omega-N-Methylarginine; Potassium Channels; Prostaglandins; Vasodilation; Vasomotor System | 1998 |
3 trial(s) available for omega-n-methylarginine and Hypotension
Article | Year |
---|---|
NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.
Topics: Adult; Arginine; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Hemodynamics; Humans; Hypotension; Interleukin-2; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Pilot Projects; Prospective Studies | 1995 |
Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine.
Topics: Adult; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Hypotension; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Male; Middle Aged; Nitrates; omega-N-Methylarginine | 2000 |
Effect of systemic nitric oxide synthase inhibition on postexercise hypotension in humans.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Output; Cold Temperature; Enzyme Inhibitors; Female; Heart Rate; Humans; Hypotension; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phentolamine; Physical Exertion; Sympathetic Nervous System; Vascular Resistance | 2000 |
25 other study(ies) available for omega-n-methylarginine and Hypotension
Article | Year |
---|---|
Symmetric dimethylarginine is an independent predictor of intradialytic hypotension.
Topics: Aged; Arginine; Biomarkers; Blood Pressure; Female; Humans; Hypotension; Kidney Failure, Chronic; Male; Middle Aged; omega-N-Methylarginine; Predictive Value of Tests; Renal Dialysis | 2008 |
Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome.
Topics: Animals; Blood Pressure; Capillary Leak Syndrome; Carcinoma, Renal Cell; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hypotension; Interleukin-2; Manganese; Melanoma; Methylene Blue; Mice; Mice, Inbred Strains; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Organometallic Compounds; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Soluble Guanylyl Cyclase; Superoxides | 2011 |
Distribution of NOS isoforms in a porcine endotoxin shock model.
Topics: Animals; Cardiomyopathies; Coronary Circulation; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Guanidines; Hemodynamics; Hypotension; Isoenzymes; Lipopolysaccharides; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Organ Specificity; Shock, Septic; Swine; Vasoconstriction; Vasodilation; Vasodilator Agents | 2008 |
Inducible nitric oxide synthase (iNOS) is not required for IL-2-induced hypotension and vascular leak syndrome in mice.
Topics: Animals; Capillary Leak Syndrome; Capillary Permeability; Genetic Predisposition to Disease; Hypotension; Interferon-gamma; Interleukin-2; Lysine; Manganese; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Organometallic Compounds | 2008 |
Is endotoxin-induced hypotension related to nitric oxide formation?
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Dogs; Endotoxins; Hemodynamics; Hypotension; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Oxygen; Random Allocation; Shock, Septic; Tumor Necrosis Factor-alpha | 1994 |
First place winner of the Conrad Jobst Award in the gold medal paper competition. Nitric oxide synthase inhibitors N-monomethylarginine and aminoguanidine prevent the progressive and severe hypotension associated with a rat model of pancreatitis.
Topics: Amylases; Animals; Arginine; Blood Pressure; Calcium; Clinical Protocols; Disease Models, Animal; Drug Evaluation, Preclinical; Fluid Therapy; Guanidines; Humans; Hypotension; Immunohistochemistry; Male; Multiple Organ Failure; Nitric Oxide; omega-N-Methylarginine; Pancreatitis; Premedication; Rats; Rats, Sprague-Dawley; Resuscitation; Severity of Illness Index | 1995 |
Reversal of refractory hypotension in septic shock by inhibitor of nitric oxide synthase.
Topics: Amino Acid Oxidoreductases; Arginine; Cardiac Output, High; Fatal Outcome; Humans; Hypotension; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Shock, Septic | 1994 |
Nitric oxide does not mediate autoregulation of retinal blood flow in newborn pig.
Topics: Animals; Animals, Newborn; Arginine; Arterioles; Female; Homeostasis; Hypercapnia; Hypotension; Hypoxia; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Retinal Vessels; Swine; Vasodilation; Vasomotor System | 1995 |
A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.
Topics: Adult; Amino Acid Oxidoreductases; Arginine; Blood Pressure; Cardiac Output; Combined Modality Therapy; Critical Care; Dose-Response Relationship, Drug; Humans; Hypotension; Male; Necrosis; Nitric Oxide Synthase; omega-N-Methylarginine; Pancreatitis; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Shock, Septic; Staphylococcal Infections | 1993 |
NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs.
Topics: Animals; Antineoplastic Agents; Arginine; Blood Pressure; Blood Urea Nitrogen; Cell Division; Creatinine; Dogs; Enzymes; Glioma; Hypotension; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukocyte Count; Lymphocytes; Male; Monocytes; Nitric Oxide; omega-N-Methylarginine; Thrombocytopenia; Tumor Cells, Cultured | 1994 |
NG-methyl-L-arginine restores arterial pressure in hemorrhaged rats.
Topics: Animals; Arginine; Arteries; Blood Pressure; Disease Models, Animal; Hypotension; Male; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Vascular Resistance | 1993 |
Inhibition of nitric oxide synthesis impairs autoregulation of local cerebral blood flow in the rat.
Topics: Animals; Arginine; Autoradiography; Blood Gas Analysis; Blood Pressure; Brain; Brain Chemistry; Cerebral Hemorrhage; Cerebrovascular Circulation; Hypotension; Injections, Intravenous; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Wistar; Vascular Resistance | 1993 |
Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats.
Topics: Animals; Arginine; Cardiac Output; Disease Models, Animal; Enzyme Induction; Hemodynamics; Hypotension; Lipopolysaccharides; Lung; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Reproducibility of Results; Stroke Volume; Tachycardia | 1995 |
Nitric oxide inhibition attenuates systemic hypotension produced by protamine.
Topics: Animals; Arginine; Blood Pressure; Cardiac Output; Cyclic GMP; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Female; Hemodynamics; Heparin; Hypotension; In Vitro Techniques; Male; Methylene Blue; Models, Cardiovascular; Myocardial Contraction; Nitric Oxide; omega-N-Methylarginine; Protamines; Rabbits | 1996 |
Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.
Topics: Animals; Aorta; Cholesterol, Dietary; Diet, Atherogenic; Echocardiography; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Hemodynamics; Humans; Hypercholesterolemia; Hypotension; Lymphokines; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Rabbits; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Secretory Rate; Swine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilation | 1997 |
Induction and role of NO synthase in hypotensive hepatic failure.
Topics: Acetylcholine; Adult; Drug Resistance; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Hepatic Artery; Humans; Hypotension; Liver Failure; Liver Transplantation; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylephrine; RNA, Messenger; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1997 |
Effects of L-NMMA and fluid loading on TNF-induced cardiovascular dysfunction in dogs.
Topics: Animals; Dogs; Enzyme Inhibitors; Hemodynamics; Hypotension; Infusions, Intravenous; Isotonic Solutions; omega-N-Methylarginine; Pulmonary Wedge Pressure; Ringer's Solution; Tumor Necrosis Factor-alpha; Venous Pressure; Ventricular Dysfunction, Left; Water-Electrolyte Balance | 1998 |
Endothelium-dependent vasodilation in response to Pseudomonas aeruginosa lipopolysaccharide: an in vitro study on canine arteries.
Topics: Animals; Coronary Vessels; Dogs; Enzyme Inhibitors; Female; Hypotension; In Vitro Techniques; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pseudomonas aeruginosa; Sepsis; Vasodilation; Vasodilator Agents | 1998 |
Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release.
Topics: Adenoviridae; Animals; beta-Galactosidase; Blood Pressure; Bradycardia; Enzyme Inhibitors; gamma-Aminobutyric Acid; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Genetic Vectors; Glutamic Acid; Heart Rate; Hypotension; Male; Medulla Oblongata; Microdialysis; Microinjections; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; omega-N-Methylarginine; Rats; Rats, Inbred WKY; Recombinant Fusion Proteins; Time Factors | 2001 |
Reversal of hypotension induced by Vibrio vulnificus lipopolysaccharide in the rat by inhibition of nitric oxide synthase.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Heart Rate; Hypotension; Lipopolysaccharides; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Vibrio | 1992 |
Cardiovascular actions of NG-methyl-L-arginine are abolished in a canine shock model using high-dose endotoxin.
Topics: Animals; Arginine; Blood Pressure; Cardiac Output; Disease Models, Animal; Dogs; Endotoxins; Escherichia coli; Heart; Hypotension; Lipopolysaccharides; Male; Nitric Oxide; omega-N-Methylarginine; Shock; Vascular Resistance; Vasoconstriction | 1992 |
Inhibition in the rat of nitric oxide synthesis in vivo does not attenuate the hypotensive action of acetylcholine, ATP or bradykinin.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Arginine; Bradykinin; Endothelium, Vascular; Glyburide; Hypotension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Inbred Strains | 1992 |
Adenosine release in morphine-induced hypotension in rats.
Topics: 2-Chloroadenosine; Adenosine; Animals; Arginine; Blood Pressure; Dipyridamole; Hypotension; Injections, Intraperitoneal; Injections, Intravenous; Male; Morphine; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Tetrabenazine; Theophylline | 1992 |
Protamine releases endothelium-derived relaxing factor from systemic arteries. A possible mechanism of hypotension during heparin neutralization.
Topics: Animals; Arginine; Arteries; Dogs; Endothelium, Vascular; Heparin; Hypotension; Nitric Oxide; omega-N-Methylarginine; Protamines; Stereoisomerism; Vasodilation | 1992 |
NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.
Topics: Animals; Arginine; Blood Pressure; Dogs; Heart Rate; Hypotension; Nitric Oxide; omega-N-Methylarginine; Recombinant Proteins; Time Factors; Tumor Necrosis Factor-alpha | 1990 |